{"doi":"10.1016/j.dadr.2025.100395","title":"Multilevel determinants of medication preferences for opioid use disorder among criminal-legal-involved populations: Insights from a scoping review","abstract":"Background: Individuals with opioid use disorder (OUD) hold varying perceptions of the three medications to treat OUD (MOUD). Data on these perceptions among those with criminal-legal involvement is limited. To optimize MOUD service delivery, especially in criminal-legal settings, it is essential to explore the preferences and attitudes of those with legal involvement. Methods: We conducted a scoping review of literature published via PubMed, Embase, Web of Science, Scopus, PsycInfo, and SocINDEX (January 1, 2014-September 17, 2024). Three-stage screening process was employed by two reviewers: title/abstract (n = 2085 articles), full-text (n = 88), and data extraction of 44 articles included in the final sample. Content analysis was used to understand preferences/attitudes toward MOUD and related influential factors. Results: Factors that influenced MOUD preferences/attitudes were clustered in positive (n = 39 articles; i.e., like), negative (n = 38; i.e., dislike), or mixed (n = 20; both positive and negative) valences. Methadone was the most referenced (n = 30), with more articles noting negative attitudes than positive. Fewer studies focused on oral buprenorphine (n = 18), with balanced positive and negative views. Seven articles on injectable MOUD highlighted mostly positive attitudes. Factors shaping preferences/attitudes spanned from individual to structural levels. Common factors associated with negative preferences included MOUD program rules, side or adverse effects, and drug-free ideology. Positive preferences were often engendered by flexible MOUD delivery and beliefs about MOUD. Influential factors differed by MOUD type. Conclusions: Preferences/attitudes toward MOUD among criminal-legal-involved populations are shaped by intersecting multilevel determinants and differ by MOUD type. Identified factors might serve as intervention targets to better meet individuals' needs.","journal":"Drug and Alcohol Dependence Reports","year":2025,"id":548694,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9518,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":322667,"name":"Jaclyn M. W. Hughto","orcid":"0000-0003-4722-8179","position":1,"is_corresponding":false},{"id":1442875,"name":"Claudia Stagoff-Belfort","orcid":null,"position":2,"is_corresponding":false},{"id":379147,"name":"Shira Dunsiger","orcid":"0000-0001-5636-0601","position":3,"is_corresponding":false},{"id":39501,"name":"Rosemarie A. Martin","orcid":"0000-0002-0412-8074","position":4,"is_corresponding":false},{"id":1153857,"name":"Amelia Bailey","orcid":"0000-0001-9006-6262","position":0,"is_corresponding":true}],"reference_count":92,"raw_metadata":null,"created_at":"2026-07-19T02:54:03.053965Z","pmid":"41362839","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}